期刊文献+

Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats 被引量:7

Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats
下载PDF
导出
摘要 BACKGROUND: Recent studies have confirmed that the expression of Ezrin, hepatocyte growth factor (HGF) and its receptor (C-met) is related to the genesis, progress, invasion and metastasis of some malignant tumors. Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors. However, there is no report on the expression levels of Ezrin, HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA). This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues, and assess its effect in cancer induction by DMBA. METHODS: Ninety Sprague-Dawley rats were divided into 3 groups randomly: 40 in a pancreatic cancer model group (group A), 40 in a trichostatin A (TSA) intervention group (group B), and 10 in a control group (group C). DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B. The rats of group B were treated with 1 ml of TSA saline solution (1 mu g/ml) via intraperitoneal injection weekly. The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile, the rats in group C were executed within 5 months. The EnVision (TM) immunohistochemistry for detecting the expression levels of Ezrin, HGF and C-met was used in paraffin-embedded sections of the pancreatic specimens. RESULTS: The incidence of pancreatic cancer in group A was 48.6% and in group B 33.3%. The maximal diameter of tumor mass was significantly larger in group A than that in group B (P<0.05). No pathological changes were observed in the pancreas of group C and other main organs of groups A and B. The positive rates of Ezrin, HGF and C-met were significantly higher in ductal adenocarcinoma than in non-cancerous pancreatic tissues of groups A and B (P<0.01). The positive rates of Ezrin, HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non-cancerous pancreatic tissues of group A (P<0.05) BACKGROUND: Recent studies have confirmed that the expression of Ezrin, hepatocyte growth factor (HGF) and its receptor (C-met) is related to the genesis, progress, invasion and metastasis of some malignant tumors. Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors. However, there is no report on the expression levels of Ezrin, HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA). This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues, and assess its effect in cancer induction by DMBA. METHODS: Ninety Sprague-Dawley rats were divided into 3 groups randomly: 40 in a pancreatic cancer model group (group A), 40 in a trichostatin A (TSA) intervention group (group B), and 10 in a control group (group C). DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B. The rats of group B were treated with 1 ml of TSA saline solution (1 mu g/ml) via intraperitoneal injection weekly. The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile, the rats in group C were executed within 5 months. The EnVision (TM) immunohistochemistry for detecting the expression levels of Ezrin, HGF and C-met was used in paraffin-embedded sections of the pancreatic specimens. RESULTS: The incidence of pancreatic cancer in group A was 48.6% and in group B 33.3%. The maximal diameter of tumor mass was significantly larger in group A than that in group B (P<0.05). No pathological changes were observed in the pancreas of group C and other main organs of groups A and B. The positive rates of Ezrin, HGF and C-met were significantly higher in ductal adenocarcinoma than in non-cancerous pancreatic tissues of groups A and B (P<0.01). The positive rates of Ezrin, HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non-cancerous pancreatic tissues of group A (P<0.05)
机构地区 Cent S Univ
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2010年第6期639-644,共6页 国际肝胆胰疾病杂志(英文版)
关键词 pancreatic neoplasms animal model EZRIN hepatocyte growth factor C-MET pancreatic neoplasms animal model Ezrin hepatocyte growth factor C-met
  • 相关文献

参考文献25

  • 1秦阳,张绍军,郭克建.维生素D衍生物EB1089对胰腺癌细胞系BxPC-3中Survivin基因及c-myc蛋白表达的影响[J].临床和实验医学杂志,2008,7(4):21-23. 被引量:2
  • 2Benjamin Bruce,Gaurav Khanna,Ling Ren,Goran Landberg,Karin Jirstr?m,Charles Powell,Alain Borczuk,Evan T. Keller,Kirk J. Wojno,Paul Meltzer,Kristin Baird,Andrea McClatchey,Anthony Bretscher,Stephen M. Hewitt,Chand Khanna.Expression of the cytoskeleton linker protein ezrin in human cancers[J]. Clinical & Experimental Metastasis . 2007 (2) 被引量:1
  • 3David Sarrió,Socorro María Rodríguez-Pinilla,Ana Dotor,Francisco Calero,David Hardisson,José Palacios.Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas[J]. Breast Cancer Research and Treatment . 2006 (1) 被引量:1
  • 4Bockman DE,Guo J,Büchler P,Müller MW,Bergmann F,Friess H.Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Laboratory Investigation . 2003 被引量:1
  • 5García-Morales P,Gómez-Martínez A,Carrato A,Martínez- Lacaci I,BarberáVM,Soto JLet al.Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. Molecular Cancer Therapeutics . 2005 被引量:1
  • 6Mallikarjuna K,,Pushparaj V,Biswas J,Krishnakumar S.Expression of epidermal growth factor receptor,ezrin, hepatocyte growth factor,and c-Met in uveal melanoma:an immunohistochemical study. Current Eye Research . 2007 被引量:1
  • 7Yeh TS,Tseng JH,Liu NJ,Chen TC,Jan YY,Chen MF.Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Archives of Surgery . 2005 被引量:1
  • 8Ogino W,Takeshima Y,Mori T,Yanai T,Hayakawa A,Akisue Tet al.High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis. Journal of Pediatric Hematology Oncology . 2007 被引量:1
  • 9Comoglio PM,Giordano S,Trusolino L.Drug development of MET inhibitors:targeting oncogene addiction and expedience. Nature Reviews Drug Discovery . 2008 被引量:1
  • 10Murai M,Shen X,Huang L,Carpenter WM,Lin CS,Silverman Set al.Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion. International Journal of Oncology . 2004 被引量:1

二级参考文献1

共引文献3

同被引文献19

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部